The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Speciality Medicines Ltd

Speciality Medicines Ltd

BSE 544738 · NSE SPML · ISIN INE0R0M01014 · Group M · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹155.05

+0.55%

BSE close, 28 August 2026

Market cap

₹136.22 cr

0.9 cr shares · Micro cap

Free float

₹36.44 cr

as published

P/E · P/B

16.6× · —

EPS ₹9.31 · BV —

Latest FY rev / PAT

—

no annual figures

Filings, window

9

1 selected · 11%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹121.10 52-WK HIGH ₹381.20 ₹155.05 13% of range
Against 52-week high-59.3%
Against 52-week low+28.0%
Day change+0.55%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹9.31
Price / earnings16.65×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q 44.78 8.18 12.54 20.21% 18.27%
Period3 · Q 75.29 13.03 20.11 19.27% 17.31%

Quarter on quarter

Revenue, quarter on quarter
-40.5%
Net profit, quarter on quarter
-37.2%
Operating margin, quarter on quarter
+94 bps

Disclosure profile 9 filings in the window

0 median 17.0 p75 · 25 sector max 52 9 11th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Press Release1
Selected sub-total1
Procedural
AGM / EGM3
General2
Annual Report1
Outcome1
Trading Window1
Procedural sub-total8
Total9

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

9 filings · 1 selected · busiest 2026-09-03 and 2026-09-28

Filing rhythm · the twelve most recent

2026-08-042026-09-28

SelectedProcedural

Filings

9 in the window · 1 earlier on record

  1. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    We hereby submit intimation regarding closure of trading Window for the Half year ended on September, 30 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.

    AGM/EGM / AGM View filing →

  3. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    We hereby submit Proceedings of 5th AGM of the Company.

    AGM/EGM / AGM View filing →

  4. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    We hereby Submit Annual Report of FY 2025-26.

    Others / Reg. 34 (1) Annual Report View filing →

  5. 3 September 2026 ·

    AGM / EGM

    Notice Of 5Th Annual General Meeting

    We hereby submit Notice of 5th AGM to be held on September 28, 2026.

    AGM/EGM / EGM View filing →

  6. 3 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On September 03, 2026

    We hereby submit Outcome of the board meeting held on September 03, 2026

    Others / Outcome without intimation View filing →

  7. 12 August 2026 ·

    General

    Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Approval For Two New Products In Ethiopia

    We hereby submit intimation regarding approval for Two new products in Ethiopia.

    Company Update / General View filing →

  8. 12 August 2026 ·

    Press Release

    Press Release / Media Release

    We hereby submit Press Release titled "Speciality Medicines Limited Secures Regulatory Approval for Two New Products in Ethiopia".

    Company Update / Press Release / Media Release View filing →

  9. 4 August 2026 ·

    General

    Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Appointment Of Investor And Public Relations Agency Of The Company

    We hereby submit the Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding Appointment of Investor and Public Relations agency of the Company.

    Company Update / General View filing →

RSS feed for Speciality Medicines Ltd · the 50 most recent filings